Several fighters who competed on this past season of Dana White’s Contender Series are facing disciplinary action from the Nevada Athletic Commission.
[autotag]Francesco Mazzeo[/autotag] and [autotag]Abdellah Er-Ramy[/autotag], who lost their respective bouts, were issued suspensions for failed drug tests, while [autotag]Quemuel Ottoni[/autotag], who pulled out of his DWCS bout hours before the fight due to anxiety, was given an extension to his suspension.
The NAC announced its rulings during a monthly meeting on Tuesday in Las Vegas.
Mazzeo (4-1) tested positive for GW1516 and GW1516 metabolites, which are prohibited at all times under the World Anti-Doping Agency, in a urinalysis collected on Sept. 24. The B sample confirmed the prohibited substances.
The Italian fighter was given a nine-month suspension retroactive from collection of the test and will be eligible to return on June 23, 2025. He was also fined $750 with prosecution fees totaling $154.04.
Er-Ramy (7-2) faced a similar fate to Mazzeo. After testing positive for drostanolone and drostanolone metabolites, prohibited under the WADA list, in an Oct. 1 urinalysis, Er-Ramy was issued a nine-month suspension starting the day of the contest. His suspension lifts on June 30, 2025. He was also fined $750 with prosecution fees totaling $154.04.
For Ottoni (12-3), his temporary suspension was extended for the NAC’s January meeting, as the NAC continues negotiations with the fighter and look to “re-establish contact.” Ottoni has tested positive for Clomiphene.
[lawrence-auto-related count=3 category=420030788]